Knowledge, Trust, and the Limits of Technology in Population Health: In conversation with Professor Howard Bauchner

The November 2025 conversation with Professor Howard Bauchner offered a rare vantage point. Drawing on his career as an academic, clinician, and former Editor-in-Chief of the Journal of the American Medical Association (JAMA), Bauchner reflected on what fifty years of scientific progress reveal — and what they do not — about improving population health in an era of digital acceleration.

What emerged was neither technological optimism nor scepticism, but a revealing proposition that science is advancing rapidly, yet health systems’ capacities to translate evidence into equitable health outcomes is struggling to keep pace.

Extraordinary science, uneven gains.

Few Editors-in-Chief have had as panoramic a view of medical science and biomedical innovation as Bauchner. From that unique vantage point he has been stunned by scientific progress, highlighting the gene therapies that can cure children with sickle cell disease, new classes of drugs reshaping the treatment of obesity, and major advances in cardiovascular disease and cancer survival that would have been unimaginable only decades ago.

Yet these successes sit alongside stubborn challenges. Dementia and Alzheimer’s disease remain largely resistant to effective intervention. Mental health outcomes, including among health workers, appear to be worsening rather than improving. And even for conditions that are inexpensive to diagnose and treat — such as hypertension and high cholesterol — global performance remains poor, despite decades of accumulated evidence.

Bauchner’s take home lesson is not that science is failing, but that scientific progress does not automatically equate to implementation or behavioural change. Advances in knowledge, he argued, will not translate into population-level gains without explicit attention to institutional capacity, political commitment, and continuity of stewardship.

Trust under strain.

One of his most sobering reflections concerned trust in science.

Before the COVID-19 pandemic, global vaccine hesitancy hovered at low single digits. It is now measured in the tens of percent worldwide. This erosion of trust cannot be explained solely by misinformation or political interference; it also reflects failures of communication, curation, and governance within science.

At the same time, the volume of biomedical research has doubled in little more than a decade. The abundance of data now makes it possible to generate almost any outcome one wishes to find. The challenge facing journals, universities, and funders is no longer simply how to produce knowledge, but how to ensure its integrity, coherence, and credibility.

From Bauchner’s perspective, this places renewed emphasis on editorial judgment — a quality that cannot be automated or outsourced to AI— and on diversity of perspective, not only in demographic terms but in intellectual orientation. Scientific institutions that converge too quickly around dominant narratives risk losing precisely the critical tension that sustains trust.

Equity as a structural question. 

The conversation also underscored how deeply equity is embedded in the architecture of health systems. Whether in lower-income countries facing stalled progress on infectious disease, or in high-income systems where minority and low-income populations receive systematically poorer care, inequity remains a defining feature of global health.

Crucially, Bauchner resisted framing this solely as a problem of medicine. He argued that the strongest determinants of population health — education, housing, income, and social security — sit squarely within the remit of government. Echoing the work of Sir Michael Marmot, he argued that clinical care matters, but its influence is marginal when set against the structural effects of poverty and the social determinants of health.

This distinction matters because it places limits on what advanced health technologies can achieve. When responsibility for social determinants drifts into healthcare by default, systems risk over-medicalising problems that are fundamentally political and economic.

AI: powerful, partial, and insufficient.

Artificial intelligence looms large in contemporary health discourse, often framed as a solution to workforce shortages or a replacement for human expertise. Even Bill Gates imagines AI will replace doctors. Bauchner’s assessment was more restrained.

AI already performs well in bounded tasks — image interpretation, pattern recognition, administrative support — and may relieve some of the burden that has contributed to clinician burnout. Yet, what remains largely unproven is whether AI meaningfully improves patient outcomes, rather than increasing detection or administrative efficiency. More importantly, AI does little to address the core drivers of population health. It cannot, on its own, reduce poverty, improve housing quality, or ensure educational attainment.

In this sense, AI sharpens an old insight rather than overturning it: technology amplifies systems as they are. Where governance is weak or inequitable, digital tools risk reinforcing existing disparities rather than correcting them.

Stewardship, not disruption.

Perhaps the most consistent thread running through the conversation was the importance of stewardship. Health systems, Bauchner noted, are often damaged as much by repeated structural upheaval as by underfunding. Constant reorganisation within a health system exhausts the health workforce it depends on and erodes institutional memory, precisely when long-term challenges — ageing populations, chronic disease, workforce sustainability — demand stability.

From this perspective, Bauchner positions himself in the school of thinking that the future of population health may be less about discovering the next breakthrough than about sustaining the conditions under which existing knowledge can be applied equitably and at scale. That requires political patience, fiscal commitment, and a willingness to invest in local experimentation and quality improvement rather than to continuously reinvent from the top-down.

Vanguard ‘moment’.

This conversation in the King’s Vanguard series set a deliberate tone. It highlighted the tensions in health systems: between innovation, implementation, and investment responsibility; the abundance of knowledge/evidence yet a scarcity of trust, and; medical capability versus political stewardship of health determinants. In so doing, it resisted the simple narrative or dichotomous argument too often employed in politics.

Professor Bauchner’s Vanguard ‘moment’ - a succinct message to either academia or government – was illustrative of these tensions. When asked what he would advise the Rt Hon Wes Streeting, Secretary of State, to consider as the UK’s steward for health and care services, he highlighted:

1. No health reform will succeed unless funding is maintained or increased over the next decade. That’s essential.
2. The NHS needs stability. It’s undergone eight major reorganisations in the past 15–20 years. The workforce can’t absorb constant restructuring.
3. Allow local experimentation. Give certain trusts real latitude to innovate in how they spend resources. If it works, scale it.
4. And address inequity — understand who isn’t receiving appropriate care and why.

That message would likely resonate in many high-, middle- and low-income country settings: intentional investment in the health workforce and in local systems to identify and scale improvements for population health.